LAB ON A CHIP
Scope & Guideline
Unleashing Potential in Lab-on-a-Chip Applications
Introduction
Aims and Scopes
- Microfluidic Device Development:
The journal emphasizes the design, fabrication, and optimization of microfluidic devices, including novel materials, techniques, and methodologies to enhance device performance. - Biomedical Applications:
Research published in LAB ON A CHIP frequently focuses on biomedical applications, including organ-on-chip models, drug delivery systems, and diagnostic tools that leverage microfluidics for improved healthcare outcomes. - Integration of Technologies:
The journal highlights the integration of microfluidics with other technologies such as biosensors, imaging systems, and AI for enhanced functionality and efficiency in various applications. - Single-Cell Analysis:
A significant area of focus includes techniques for single-cell manipulation, analysis, and characterization, which are crucial for understanding cellular heterogeneity and responses. - Environmental and Food Safety:
The journal also covers applications of microfluidics in environmental monitoring and food safety, exploring innovative solutions for pathogen detection and contamination analysis.
Trending and Emerging
- AI and Machine Learning Integration:
The integration of AI and machine learning into microfluidic systems is a rapidly growing trend, facilitating enhanced data analysis, predictive modeling, and automation of experimental processes. - Point-of-Care Diagnostics:
There is an increasing emphasis on developing portable and efficient microfluidic devices for point-of-care diagnostics, particularly in response to global health challenges like the COVID-19 pandemic. - 3D and 4D Microfluidic Systems:
Research on 3D and 4D microfluidic systems is gaining momentum, allowing for more complex and physiologically relevant models that can better mimic human organ systems. - Sustainable Microfluidics:
The trend towards sustainability is evident with research focused on developing eco-friendly materials and processes for microfluidic device fabrication and operation. - Multimodal Systems for Drug Testing:
Emerging themes include the use of microfluidics in multimodal systems for drug testing and screening, incorporating various analytical techniques to assess drug efficacy and safety.
Declining or Waning
- Traditional Microfluidic Techniques:
Older microfluidic techniques that do not incorporate advancements such as AI or machine learning are becoming less common, as researchers seek more efficient and automated solutions. - Static Microfluidic Systems:
The focus on static or passive microfluidic systems is waning as dynamic systems that allow for real-time monitoring and responsive manipulation gain more traction. - Basic Fluid Mechanics Studies:
Studies that primarily focus on fundamental fluid mechanics without application to specific biomedical or technological contexts are seeing reduced interest, as the field shifts towards practical, application-driven research. - Conventional Cell Culture Methods:
Research using conventional two-dimensional cell culture methods is declining in favor of more advanced microphysiological systems that better mimic in vivo environments. - Legacy Detection Methods:
Older detection methods that do not utilize modern advancements in biosensing or imaging technologies are being overshadowed by innovative techniques that offer greater sensitivity and specificity.
Similar Journals
Bioengineering & Translational Medicine
Pioneering the Future of Healthcare InnovationBioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.
ACS Applied Bio Materials
Innovating the Future of Bioengineering and Materials ScienceACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.
Annual Review of Biomedical Data Science
Connecting Data Science with Biomedical BreakthroughsAnnual Review of Biomedical Data Science, published by ANNUAL REVIEWS, stands as a premier journal in the fields of Biomedical Engineering, Biochemistry, Genetics, and Cancer Research, with an impressive Q1 ranking across these categories in 2023. With its ISSN and e-ISSN both assigned as 2574-3414, this journal serves as a critical resource for researchers, professionals, and students looking to delve into comprehensive reviews of the rapidly evolving landscape of biomedical data science. The journal's scope includes the intersection of data science methodologies and biomedical applications, making it essential for those aiming to stay at the forefront of innovations that drive advancements in healthcare and medical research. Although it currently does not provide open access options, its commitment to high-quality research and its robust rankings—placing it in the 94th percentile in its field—underscore its significance and credibility in the academic community. Operating from the United States, with its offices located in Palo Alto, CA, this journal is a vital contributor to the discourse on the integration of data science within biomedical fields, fostering collaboration and knowledge dissemination among scholars worldwide.
Biosensors-Basel
Empowering research through open access in biosensors.Biosensors-Basel is a premier Open Access journal, published by MDPI since 2011, dedicated to advancing the field of biosensors and related technologies. With its academic headquarters in Basel, Switzerland, the journal serves as a vital resource for researchers, professionals, and students across various disciplines, including Analytical Chemistry, Biomedical Engineering, Biotechnology, and Clinical Biochemistry. Boasting an impressive range of quartile rankings—such as Q1 in Instrumentation and Q2 across several other categories—Biosensors-Basel is recognized for its high-impact research and significant contributions to the scientific community, evidenced by Scopus rankings that place it among the top journals in its field. The journal's open-access model ensures that cutting-edge findings are accessible to a global audience, promoting collaboration and innovation in biosensor technology and its applications. Scholars and professionals looking to stay on the forefront of this dynamic field will find Biosensors-Basel an indispensable platform for sharing knowledge and fostering advancements.
Materials
Catalyzing innovation through accessible research in materials.Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.
APL Bioengineering
Pioneering Solutions for Biomedical ChallengesAPL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.
BIOSENSORS & BIOELECTRONICS
Empowering Scientific Dialogue in Biomedical EngineeringBIOSENSORS & BIOELECTRONICS, published by Elsevier Advanced Technology, is at the forefront of research and innovation in the realms of biomedical engineering, biophysics, and biotechnology. Established in 1990, this esteemed journal has established itself as a premier platform, receiving a prestigious Q1 ranking across multiple categories, including Electrochemistry and Nanoscience, reflecting its critical impact on advancing scientific knowledge and technology. With an impressive range of topics, including the latest trends in biosensor development and bioelectronic application, it serves as an invaluable resource for researchers, professionals, and students alike, facilitating collaborative dialogue and innovative solutions. Though primarily subscription-based, the journal is accessible from its UK headquarters in Oxford, promising rigorous peer-reviewed articles that inform future trends and applications in this dynamic field.
Advanced Biomedical Engineering
Pioneering breakthroughs in biomedical innovation.Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS
Transforming data into discovery in the laboratory landscape.Chemometrics and Intelligent Laboratory Systems is a distinguished journal published by Elsevier, disseminating pivotal research and innovations at the intersection of analytical chemistry, computer science applications, and chemical engineering. With an impressive impact factor reflecting its scholarly influence, the journal aims to advance the development and implementation of chemometric methods, artificial intelligence, and intelligent systems in laboratory settings. Since its inception in 1986, the journal has consistently featured high-quality articles, currently positioned in the Q2 quartile across multiple relevant fields including Analytical Chemistry and Process Chemistry. Based in the Netherlands, the journal invites rigorous contributions that enhance the understanding and application of sophisticated data analysis techniques in scientific research. Although it currently does not offer open access options, the journal remains a vital resource for researchers and professionals dedicated to exploration and advancements in laboratory methodologies and analytical technologies.
ASAIO JOURNAL
Innovative Insights for the Future of MedicineThe ASAIO Journal, published by Lippincott Williams & Wilkins, stands as a premier platform in the realm of bioengineering and biomedical innovation, with a rich history spanning from 1978 to present. Renowned for its rigorous peer-reviewed content, the journal holds an impressive impact factor categorized as Q1 in Biomedical Engineering and Q1 in Biophysics for 2023, signaling its critical role in advancing knowledge and research in these pivotal fields. The journal's domain extends into diverse topics within biophysics, biomaterials, and miscellaneous areas of medicine, making it a vital resource for researchers, professionals, and students alike. Through its commitment to showcasing pioneering research and fostering scientific dialogue, the ASAIO Journal reinforces its position as a key contributor to the ongoing development of innovative medical solutions. Researchers and practitioners can access a wealth of knowledge that is essential for staying at the forefront of technology and methodologies that shape the future of healthcare.